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Background: While video-assisted thoracic surgery lobectomy has been widely accepted for the treatment of
non–small cell lung cancer, the debate over video-assisted thoracic surgery segmentectomy still remains. This study
compared the clinical outcomes using the two procedures for stage I non–small cell lung cancer patients.
Methods: Retrospective review was conducted on patients who underwent video-assisted thoracic surgery
segmentectomy or lobectomy for clinical stage I non–small cell lung cancer at Shanghai Chest Hospital between
November 2009 and May 2012. Video-assisted thoracic surgery segmentectomy was performed on 36 patients and
video-assisted thoracic surgery lobectomy on 138 patients. Comparisons between the 2 groups were performed in
patient demographic and clinical characteristics, intraoperative parameters and oncology outcomes.
Results: Mean volume of chest tube drainage after operation was smaller for segmentectomy than for lobectomy
(1021 ml vs. 1328 ml, P=0.036). Other parameters analysis including blood loss, operation time, chest tube duration
and length of hospital stay favors the segmentectomy group numerically without significance. There was no
significant difference in distributions in both intra and post operative complications. There was one peri-operative
mortality from segmentectomy group and all other patients are alive with a median follow up of 327 days. There
were 1 (2.8%) locoregional recurrence after segmentectomy and 6 recurrences (4.4%) after lobectomy (P=1.00).
Multivariate survival analysis revealed no significant difference in recurrence-free survivals between the two groups.
Two patients successfully underwent bilateral segmentectomies and are free of disease.
Conclusions: For patients with stage I non–small cell lung cancer, video-assisted thoracic surgery segmentectomy
offers a safe and equally effective option and can be applied to complicated operation such as bilateral
segmentectomy.Background
Non-small cell lung cancer (NSCLC) represents approxi-
mately 80% of all lung cancers [1] and the traditional
treatment for stage I NSCLC is lobectomy. In 1973,
Jensik et al [2] published a study suggesting that seg-
mental resection was equivalent to lobectomy and repre-
sented an adequate operation for stage I NSCLC. This
publication started a debate regarding the optimal surgi-
cal approach for early stage NSCLC. Recently, as a result* Correspondence: qingquan.luo.shch@gmail.com
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reproduction in any medium, provided the orof an increasing incidence of small lung tumors, there
has been renewed interest in the use of anatomic
segmentectomy, especially for patients with stage IA
NSCLC and those unable to tolerate lobectomy because
of compromised medical condition. Several recently
published studies have shown that segmentectomy could
be performed safely without compromising oncologic re-
sults if patient selection for sublobar resection was ad-
equate [3-8].
Video-assisted thoracic surgery (VATS) has been intro-
duced in a variety of thoracic operations, including
small-sized lung cancer. VATS is less invasive and pro-
vides benefits due to decreased postoperative pain,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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improved tolerance of chemotherapy [9-16]. VATS can
be generally classified into two categories of Hybrid-
VATS and Complete-VATS (C-VATS). C-VATS, the pure
video-based operation was the procedure we used in our
studies.
Despite the growing acceptance of VATS lobectomy,
VATS segmentectomy, especially C-VATS segmentectomy
has not become widespread and remains highly controver-
sial as a choice for treatment of small lung tumors. In
addition to concerns about increased locoregional recur-
rence, potential arguments against VATS segmentectomy
include higher rates of complications and inadequate
nodal dissection because of the high complexity of the
procedure [5,17]. To date, there is scanty of data from
published studies comparing clinical outcomes between
VATS segmentectomy and VATS lobectomy except the
data from Japan and US groups on selected patients
[1,18]. The purpose of this study was to offer a compre-
hensive evaluation of the clinical outcomes of complete
VATS segmentectomy compared with VATS lobectomy in




In this retrospective study, 174 stage I NSCLC patients
were operated on at the Shanghai Chest Hospital (Shanghai,
China) between November 2009 and May 2012. VATS
segmentectomy was performed on 36 patients, and VATS
lobectomy on 138 patients. Both procedures were accom-
panied by systemic lymphadenectomy. Principally, all pa-
tients were operated with curative intent under C-VATS.
The hospital center board of management approved
the conduct of this study including a waiver of individual
patient consent during data collection due to the retro-
spective nature of the study. Inpatient and outpatient
charts were reviewed, and all the data including demo-
graphic data, histopathologic categorization, pathologic
staging, number of nodal stations resected, number of
lymph nodes resected, operative courses, intraoperative
blood loss, total volume of chest tube drainage after op-
eration, chest tube duration, postoperative hospital
courses and information of recurrence were collected
with patients’ consent. Patients were contacted for add-
itional follow-up information with a standardized ques-
tionnaire every 6 months (or every 3 months when
necessary). Operative mortality was defined as death
within 30 days of the procedure. Pathologic cancer sta-
ging was done in accordance with TNM-7 for the sta-
ging of NSCLC (2009).
Before surgical resection, all patients underwent pre-
operative examinations including ECG, chest X-rays, ab-
dominal ultrasound, pulmonary function test, chest CTscanning (3D reconstruction when necessary), enhanced
head MRI and bone scanning. Patients selected for
segmentectomy must fulfill the following criteria: 1)
compromised pulmonary reserve with extensive comor-
bidities, and without the ability to endure lobectomy, 2)
peripheral location of the tumor with the biggest diam-
eter ≤ 2 cm, and bronchioloalveolar carcinoma (BAC)
simplex and/or ground-glass opacity of nodules ≥ 50%
as shown by CT scanning, and 3) Tumor doubling time
(TDT) ≥ 400 days as demonstrated by follow-up imaging
examination. Patients selected for lobectomy must fulfill
the following criteria: 1) patients with no anatomic or sur-
gical contraindications; 2) No compromise of standard on-
cologic and dissection principles of thoracic surgery.
The standard preoperative evaluation and algorithm of
segmentectomy assessments and procedures are shown
in Figure 1. Patients whose operation converted to
thoracotomy were considered censored on the date of
operation when survival analysis was performed and
were part of the intent-to-treat population.
Operation technique
Selection of incisions: 3-ports or 4-ports approach
Observation port It is typically at midaxillary line and
the 7-8th intercostal space about 0.5-1 cm in length. It is
primarily used for placing trocar lens of thoracoscope
into thoracic cavity, and reserved for the placement of
upper chest tube.
Main operation port It is generally placed at the inter-
section of anterior axillary line and the 4th intercostal
space and about 2–5 cm in length. The use of an inci-
sion protection sleeve will protect the incision from
tumor-seeding. The size and position of the port can be
adjusted according to the tumor. After the operation,
the port will be sutured.
First accessory operation port It is usually placed at
the intersection of posterior axillary line and the 8-9th
intercostal space. It can be positioned visually with the
aid of a thoracoscope, thus avoiding the operation in-
convenience and postoperative pain by not causing in-
jury or touching the diaphragm. This port is usually
used for traction and exposition of the tissues and for
the placement of anastomat and ultrasound knife into
thoracic cavity. Since it is near the costophrenic angle, it
is usually reserved for the placement of the lower chest
tube after the operation.
Second accessory operation port It is usually placed at
the intersection of posterior axillary line and the 5-6th
intercostal space, or closer to the subscapular angle line.
It may not be needed if the operation is simple. This
Figure 1 Standard preoperative evaluation and algorithm of assessments and procedures.
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ovalforceps and pulmonary forceps into the thoracic cavity
to expose tissues. It will be sutured after operation.
Operative procedures for VATS segmentectomy
Exploration and identification Generally, specific pos-
ition of tumor can be accurately located by CT scanning
or three dimensional reconstructions before operation. If
necessary, the tumor can also be located by hook-wire
puncture preoperatively [19]. During the operation, the
position of the tumor is reconfirmed via finger palpation.
Resection margins to the tumor After the location of
the tumor had been confirmed, we also used an electric
knife (argon gas) to provide a contour of the margins.
This was further assisted by segmental lung inflation. In
case the estimated distance to the margins is shown to be
less than 2 cm, use of original margins (> 2 cm) would still
be upheld in order to completely resect the tumor.
Handling of important lung segments All patients of
the VATS segmentectomy group received the anatomic
resection with the arteries, veins and bronchial structure
of targeted lung segments completely isolated and
processed as described in previous reports [15].
Handling of segmental fissure /lung tissue Generally,
there are no obvious fissures between two segments.
Moreover, the tissue of lung is relatively thick and con-
siderations should be taken when choosing the appropri-
ate anastomat.
The specimens are usually taken out of thoracic cavity
from the main operation port after being placed into an
aseptic bag. This is followed by immediate exploration.
It should be noted that the distance of segmentalresection margin to the tumor must be ≥ 2 cm. If the
distance is < 2 cm, extended segmentectomy or pulmon-
ary lobectomy, will have to be considered. In our series
of patients, we have been consistent and stick to the rule
that the surgical margins must be ≥ 2 cm as the margin
has been considered necessary to avoid relapse. We did
not have patients whose surgery had to be compromised
for this rule.
After being rinsed and soaked with aseptic distilled
water, the thoracic cavity is carefully examined by the sur-
geon to identify any active bleeding. Afterwards, the sam-
ples are sent for frozen section pathology examination.
Operative procedures for VATS lobectomy
Up to now, convention has already been established ba-
sically for VATS lobectomy depending on specific situ-
ation such as interlobar fissure. The commonly used
methods include RJ.Mckenna’ sequential thoracoscopic
lobectomy [20], Liu’s single-direction thoracoscopic lob-
ectomy [21] and Wang’s thoracoscopic lobectomy [22].
Lymph nodes dissection
If lung cancer is confirmed by intraoperative frozen section,
systematic lymphadenectomy will be performed for both
VATS segmentectomy and VATS lobectomy according to
the commonly accepted international guidelines. After the
lymphadenectomy, “skeletonized” is achieved for important
structures. Additionally, parabronchial lymph nodes, seg-
mental lymph nodes and sub-segmental lymph nodes
(groups 12, 13 and 14) are required to be dissected as thor-
oughly as possible for VATS segmentectomy.
Hemostasis
Hemostasis is performed carefully after the lymph nodes
dissection, and the thoracic cavity is rinsed and soaked
with aseptic distilled water again. Then the lung is inflated
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leakage at the residue of bronchus. To reduce drainage
volume after lymphadenectomy, the spaces left are padded
with hemostatic gauze. Two chest tubes (the upper and
the lower) are usually kept after operation.
Statistical analysis
All statistical analysis was performed using SAS version
9.2 (SAS institute Inc., USA). The t-test was used for
continuous data, and Chi-square test was used for cat-
egorical data. Recurrence-free survival was estimated
with the Kaplan-Meier method and evaluated by log-
rank test. Recurrence-free survival was defined as the
time from surgery to the first diagnosis of local, regional,
or distant disease recurrence or until the last follow-up.
Cox regression analysis was used to quantify hazard ra-
tios of treatment procedures with respect to recurrence-
free survival while allowing for significant covariates.
Statistically significant differences were set as P < 0.05.
Based on the results of univariate analysis, significant co-
variates of tumor size, tumor stage and histology were
next chosen in the Cox model. Here an all-factor model
was used to show hazard ratios of the two procedures
allowing for these covariates.
Results
Demographic and clinical characteristics of the patients
During the stated period, 174 patients with stage I
NSCLC underwent complete VATS in our hospital.
VATS segmentectomy was performed on 36 patients,
and VATS lobectomy on 138 patients. Both procedures
were accompanied by systemic lymphadenectomy. One
patient in segmentectomy group died of cerebral infarc-
tion 7 days post operation, and his death had no
relationship with the procedure as judged by the investi-
gators. The 30-day mortalities were 2.8% and 0.0% in
VATS segmentectomy group and VATS lobectomy
group, respectively. Clinicopathologic factors are shown
in Table 1. Stage IA comprised 137 patients, and stage
IB 37. Their ages ranged from 36–81 years with a mean
of 59.3 years for segmentectomy, and 35–81 years with a
mean of 58.8 years for lobectomy. The two groups had
similar distribution in age and sex. However, mean
tumor size (maximum tumor diameter) in the VATS
segmentectomy group was significantly smaller than in
the VATS lobectomy group (14.2 vs. 19.8 mm, P = 0.002;
Table 1). The distribution of stage IA and IB was also
significantly different between segmentectomy and lobec-
tomy (P = 0.001). The histopathology distribution was dif-
ferent between segmentectomy and lobectomy (P = 0.031),
with adenocarcinoma (ADC) and bronchiolo-alveolar car-
cinoma (BAC) accounting for 61.1% and 25.0% in the
segmentectomy group, while in lobectomy group, the per-
cent of ADC was predominantly higher (80.4%). Thelocalization of the tumor was 110 (18 for segmentectomy
and 92 for lobectomy) in the right lung and 66 (20 for
segmentectomy and 46 for lobectomy) in the left lung. 3
patients in our study successfully underwent multiple
segmentectomies and 2 of them underwent bilateral
segmentectomies as their bilateral primary lesions were
found in both lungs. They are free of recurrence and well
now. A list of resected segments is shown in Table 2.
Intraoperative parameters and complications
Total mean volume of chest tube drainage after oper-
ation were smaller for segmentectomy than for lobec-
tomy (1021 ml vs. 1328 ml, P=0.036). Other parameters
including blood loss, operation time, chest tube duration
and length of hospital stay favor the segmentectomy
group numerically without significance (Table 3).
Intraoperative bleeding was the only reason of conver-
sions to minithoracotomy for one patient in the
segmentectomy group (2.8%) and six patients in the lob-
ectomy group (4.3%) as seen in Table 4, respectively. For
the patient under segmentectomy, his hemostasis was
achieved by video-assisted angiorrhaphy during the oper-
ation. 1500 ml of blood was given to this patient during
the surgery; however, he did not have any intraoperative
hemodynamic instability. These conversions were assessed
as unrelated to the procedure under study as judged by
the investigators.
Specific intraoperative and postoperative complica-
tions after each procedure are listed in Table 4. During
the operation, there was 1 case of hemorrhoea in VATS
segmentectomy group, 6 cases of hemorrhoea and 4
cases of pleural adhesions in VATS lobectomy group.
The incidence rates of intraoperative complications were
not significantly different (2.8% versus 7.2%, P = 0.80).
As for postoperative complications, the incidence differ-
ence between groups was not significant, either (8.3% ver-
sus 2.2%, P = 0.07). There were 1 case of pneumoderma
and 2 cases of hypoxemia in VATS segmentectomy group,
and 1 case of pneumoderma, 1 case of air leakage and 1
case of hemorrhoea in VATS lobectomy group.
Local recurrence, distant metastases, and recurrence-free
survival
As shown in Table 5, 1 (2.8%) of 36 segmentectomy pa-
tients and 6 (4.4%) of 138 lobectomy patients relapsed
during the follow-up period with a median follow up of
327 days and the difference was not significant (P= 1.00).
The locoregional recurrence rate was low in both groups,
with 1 case (2.8%) in VATS segmentectomy group and 3
(2.2%) in the lobectomy group. Up to date, there are
no cancer related mortalities in both groups. Further-
more, recurrence-free survivals were also similar between
the groups (P=0.63) and numerically favored the
segmentectomy group (Table 6, Figure 2). Multivariate
Table 1 Demographic and clinical characteristics
Charecteristics Segmentectomy (N=36) Lobectomy (N=138) Total (N=174) P
Age (years, mean ± SD) 59.3 ± 13.77 58.8 ± 10.77 58.9 ± 11.41 0.82
Sex (male/female) 12:24 52:86 64:110 0.70
Tumor size(mm, mean ± SD) 14.2 ± 7.15 19.8 ± 9.82 18.6 ± 9.58 0.002
Histology (No, %)* 0.031
ADC 22 (61.1%) 111 (80.4%) 133 (76.4%)
BAC 9 (25.0%) 20 (14.5%) 29 (16.7%)
others 5 (13.9%) 7 (5.1%) 12 (6.9%)
Stage (No, %) 0.001
IA 35 (97.2%) 102 (73.9%) 137 (78.7%)
IB 1 (2.8%) 36 (26.1%) 37 (21.3%)
P<0.05 is considered statistically significant.
* ADC:adenocarcinoma, BAC:bronchioloalveolar carcinoma.
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histopathological classification into consideration also
showed no significant difference in the rate of recurrence
between two types of resection (Table 6).
Discussion
The debate over whether segmental resection was
equivalent to lobectomy as an adequate operation for
stage I NSCLC can be dated back to 1973 [2]. The re-
sults of the first randomized trial were published by the
Lung Cancer Study Group (LCSG) in 1995 where
sublobar resection was shown to have a three-fold in-





Left lower lobe 15
S6 8




Total left lobe 46 20
Right lower lobe 26
S6 7
Right lower middle lobe 1
Right middle lobe 12
Right upper lobe 52
S1 7
S2 4
Right upper middle lobe 1
Total right lobe 92 18
Note: lesions from different segments of same patient are counted separately.However, reports almost two decades later have showed
that anatomical segmentectomy provided compatible re-
sults in the recurrence rates and survival if adequate se-
lection (stage IA and IB) was performed for NSCLC
[3,24]. Okada et al. compared the results of anatomical
segmentectomy with lobectomy and wedge resection in
small-sized NSCLC [25]. The 5-year cancer-specific sur-
vivals of patients with pathologic stage I disease with tu-
mors of 20 mm or less in diameter were 92.4% after
lobectomy, 96.7% after segmentectomy, and 85.7% after
wedge resection, respectively. Another study indicated a
lack of difference between segmentectomy and lobec-
tomy in patients with tumors less than 2 cm in diameter
[26]. These results support segmentectomy as one of the
operative options to cure small NSCLC. Our study is the
only one to date to provide a comprehensive comparison
on peri-operative and post- operative morbidity, recur-
rence and survival between VATS segmentectomy and
VATS lobectomy among Chinese patients.
Although the use of the VATS procedure for lung can-
cer has increased in the past several years, and minim-
ally invasiveness has been shown in previous reports
[27], most of these procedures were applied for lobec-
tomy and wedge resection, but rarely segmentectomy.
The hesitancy of using VATS segmentectomy may be at-
tributed to surgical complexity, concerns regarding in-
creased morbidity related to prolonged air leak and local
recurrence rates. To date, there are few publications on
VATS segmentectomy in small lung cancers except for
Japanese and American groups among highly selected
patients [1,18] and none has been reported among Chin-
ese patients.
Selection of patients following the criteria of NCCN
[28] proved to be an important factor in our successful
operations. In addition, the location of the tumor needs
to be determined precisely using CT or other assisted
technologies as according to the plan. This will guide
Table 3 Intraoperative parameters
Parameters Segmentectomy (N=36) Lobectomy (N=138) Total (N=174) P
Operation time (h) Mean (S.D) 124.8 (45.29) 127.2 (35.16) 126.7 (37.35) 0.73
Median 112.0 122.5 119.5
Min, Max 75, 271 67, 232 67, 271
Intraoperative blood loss (ml) Mean (S.D) 162.5 (257.84) 180.4 (201.86) 176.7 (213.94) 0.66
Median 100.0 100.0 100.0
Min, Max 50, 1600 50, 2000 50, 2000
Total volume of chest tube drainage after operation (ml) Mean (S.D) 1021.4 (591.72) 1328.9 (819.34) 1264.9 (785.96) 0.036
Median 810.0 1030.0 1000.0
Min, Max 310, 2540 350, 4890 310, 4890
Chest tube duration (day) Mean (S.D) 4.1 (1.41) 4.5 (1.78) 4.4 (1.72) 0.14
Median 4.0 4.0 4.0
Min, Max 2, 8 2, 12 2, 12
Postoperative hospital stay (day) Mean (S.D) 6.2 (1.62) 6.5 (1.87) 6.4 (1.82) 0.38
Median 6.0 6.0 6.0
Min, Max 4, 11 4, 14 4, 14
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on our experience, single segmentectomy may not be suf-
ficient for those tumors located in the intersections of sev-
eral segments as the resection margin to the tumor cannot
be guaranteed and thus the risk of recurrence may in-
crease. Consequently, multi-segmentectomies or lobec-
tomy is obviously called for in these cases to achieve the
purpose to eradicate of the disease.
Due to its underlying structure of the artery and bron-
chus, not every segment is amenable to anatomic resec-
tion. Those segments which are generally held to be
resectable are located in the apical right upper segment,
posterior segment, dorsal right lower segment, posterior
left upper segment plus anterior (inherent upper), the
lingual and left posterior dorsal segments. Anterior
upper segment was anatomically considered difficult to
resect and we were able to successfully perform theTable 4 Intraoperative and postoperative complications
Segmentecto
n (%
Intraoperative complication hemorrhoea 1 (2.8
pleural adhesions -
total 1 (2.8





*P<0.05 is considered statistically significant.operation on one patient. We agreed that composite
basilar segment is the most difficult one to perform ana-
tomic resection [29].
Extreme care should also be taken when addressing the
parenchymal surgical margins for segmentectomy. After
dividing the blood vessels and segmental airway that tether
the lung, focus will be on determining the resection mar-
gin to the primary tumor. Among factors such as inflation
of clapped bronchus and injection guided by bronchos-
copy to determine the resection margin, the physical
distance to the margin was considered to be most import-
ant factor to reduce relapse for segmentectomy patients
[30]. 2 cm margin has been considered necessary to avoid
relapse [29]. The low recurrence rates we observed in
our study may also be attributed to the conservative ap-
proach adopted when determining resection margins to
the tumor.my (N=36) Lobectomy (N=138) Total (N=174) P
) n (%) n (%)
%) 6 (4.3%) 7 (4.0%)
4 (2.9%) 4 (2.3%)
%) 10 (7.2%) 11 (6.3%) 0.85
%) 1 (0.7%) 2 (1.1%)
1 (0.7%) 1 (0.6%)
1 (0.7%) 1 (0.6%)
%) - 2 (1.1%)
%) 3 (2.2%) 6 (3.4%) 0.07
Table 5 Local recurrence and distant metastases
Characteristics Segmentectomy (N=36) Lobectomy (N=138) Total (N=174) P
n (%) n (%) n (%)
Recurrences distant 0 3 (2.2%) 3 (1.7%) 1.00
locoregional 1 (2.8%) 3 (2.2%) 4 (2.3%) 1.00
total 1 (2.8%) 6 (4.4%) 7 (4.0%)
Distant metastases brain and bone metastases 0 1 (0.7%) 1 (0.6%) 1.00
bone metastasis 0 1 (0.7%) 1 (0.6%)
pericardial effusion 0 1 (0.7%) 1 (0.6%)
total 0 3 (2.1%) 3 (1.8%)
Local recurrences offside 1 (2.8%) 1 (0.7%) 2 (1.1%) 0.61
ipsilateral - 2 (1.4%) 2 (1.1%)
total 1 (2.8%) 3 (2.2%) 4 (2.2%)
*P<0.05 is considered statistically significant.
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the VATS segmentectomy group presented with smaller
amount of drainage compared with VATS lobectomy
group. This may be attributed to the relatively small cavity
left after segmentectomy, and can soften the postoperative
distress and lead to earlier recovery of patients after the
procedure. For the remaining intraoperative parameters
including operation time, intraoperative blood loss, chest
tube placement duration and postoperative hospital stay,
there were no significant differences between the 2 groups.
Furthermore, the rates of both intraoperative (2.8% versus
7.2%, P > 0.05) and postoperative complications (8.3%
versus 2.2%, P > 0.05) were not significantly different be-
tween segmentectomy and lobectomy. The lack of signifi-
cant difference was consistent with a previously published
report [18]. However, our rates are much lower than those
in other reports, in which the average rates of postopera-
tive complications were 17.6% to 31.3% after VATS
segmentectomy, 32% to 39% after open segmentectomy,
and 15.3% to 23.8% after VATS resection [9,15,24,31,32].
The explanation for the gap of rates may well be that onlyTable 6 Multivariate analysis of factors predicting
recurrence among patients with stage I non–small cell
lung cancer
Risk factor HR 95% CI P
Segmentectomy versus lobectomy 0.52 0.10~2.74 0.44
tumor sizes 1.19 0.47~3.00 0.72
tumor stage 0.86 0.12~6.03 0.88
histology
BAC versus AD 0.00 0.00~ 1.00
OTHER versus AD 0.00 0.00~ 1.00
ADC: adenocarcinoma, BAC: bronchioloalveolar carcinoma.severe cases were counted in our study and improvement
of techniques and knowledge over time.
In the last decade, a growing number of published stud-
ies have demonstrated that segmental resections achieve
comparable oncologic and survival outcomes to lobecto-
mies [3-7,24]. Schuchert et al. [3] published results of 182
segmentectomies (done with thoracotomy and VATS) and
246 lobectomies in patients with NSCLC stage IA and IB.
Similar overall recurrence rates were observed after
segmentectomy (17.6%) and lobectomy (16.7%). Again,
similar recurrence rates between segmentectomy and lob-
ectomy were reported by Shapiro et al. [18] (overall recur-
rence rates: 17.2% versus 20.4%) while Yamashita et al. [1]
reported lower rates (locoregional recurrence rates: 7.9%
versus 5.6%; distant metastasis rates: 5.3% versus 5.6%). In
our study, the recurrence rates were lower than the above
published data. Our overall recurrence rate in the VATS
segmentectomy group was 2.8%, versus 4.4% in the VATS
lobectomy group. Specifically, the locoregional recurrence
rates and distant metastasis rates were 2.8% and 0.0% for
VATS segmentectomy and 2.2% and 2.2% for VATS lobec-
tomy, respectively. Our low recurrence rates are halved
when comparing to those of Japanese group as we have
roughly followed up patients half as long (average of
327.0 days versus 27.5 months). Again, our lower recurrence
rates as well as those reported in Japan strongly suggest the
wider acceptance of VATS technique and operational im-
provement of our thoracic surgeons over the past decade.
Sienel et al. [33] pointed that the frequency of local re-
currence following segmentectomy might be influenced
by segment localization, and segmentectomy within the
S1-3 region which may have some relations with the
high local recurrence rate. The only observed local re-
currence after segmentectomy in this study occurred in
the S1-2 region and is consistent with Sienel’s results.
Figure 2 Recurrence-free survival.
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tween the 2 groups in our study, consistent with the previ-
ously reports above. In our survival analysis where
recurrence free survival time was assessed, results showed
that both procedures had the same prognosis potential,
and this agrees with the previous published reports [1,18].
The results of this study and the described recent studies
suggest that at least for current tumors, which may be
smaller and of a different histologic type than in earlier
eras, thoracoscopic segmentectomy may be an acceptable
operation from an oncologic standpoint. Moreover, as
many as 11.5% of patients undergoing surgery for lung
cancer have additional primary cancers develop within
their lifetimes and thus require additional resection [34].
Limited pulmonary resection allows future resections
through the preservation of lung volume.
So far there are few reports about VATS bilateral resec-
tion and most of the reported operations were for bilateral
lobectomy or bilateral wedge resection [35,36] and no data
have been reported on bilateral segmentectomy to our
knowledge. Among those 3 patients in our study who re-
ceived multiple segmentectomies, 2 underwent bilateral
segmentectomies and bilateral primary lesions were found
in both patients. They are free of recurrence and well now.
Our successful resection of bilateral segmentectomy has
expanded the capability of VATS thoracic surgeons with
a new list of resectable segments and no doubt more
patients will benefit from the technical advance when lob-
ectomy is not an option due to compromised lung function.
Our results from multivariate Cox regression model ana-
lysis were consistent with those from other reports [1,18].
The two resection procedures as well as histopathologictypes were not related to recurrence rates as risk factors.
Although contrary to the general acknowledge tumor stage
and tumor size were not found to be indicators of recur-
rence, this may well be because of small number of recur-
rence observed due to relatively short follow up.
The limitations of this study lie in the retrospective na-
ture of the study where the selection of patients was not
random and patient selection bias is likely. As a conse-
quence, the inherent differences in the tumor size and
follow-up period between VATS segmentectomy and
VATS lobectomy are difficult to address objectively. Rela-
tively short follow up periods and thus small number of
recurrences and mortalities may reduce the power to de-
tect difference if any between the two procedures. We
plan to continue to closely follow up on these patients.Conclusions
VATS segmentectomy is a safe and equally effective op-
tion for selected patients of stage I NSCLC if performed
by experienced thoracoscopic surgeons. With experience
accumulated, minimally invasive strategies can be ap-
plied to more challenging operations, such as bilateral
segmentectomy or in patients with compromised lung
function where lobectomy is not an option.Abbreviations
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